Precigen, Inc. (PGEN)
NASDAQ: PGEN · Real-Time Price · USD
4.270
+0.150 (3.64%)
At close: Apr 9, 2026, 4:00 PM EDT
4.270
0.00 (0.00%)
After-hours: Apr 9, 2026, 4:10 PM EDT
Revenue by Segment
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
| 9.68M | 3.93M | 6.23M | - | - | | | | | |
Biotechnology (Startups) Growth | 146.73% | -36.95% | - | - | - | | | | | |
| - | - | - | 12.02M | 13.35M | | | | | |
| - | - | - | -9.97% | 31.37% | | | | | |
| - | - | - | 14.89M | 922.00K | | | | | |
Biopharmaceuticals Growth | - | - | - | 1515.40% | -96.53% | | | | | |
| 9.68M | 3.93M | 6.23M | 26.91M | 14.27M | | | | | |
| 146.73% | -36.95% | -76.87% | 88.61% | -55.40% | | | | | |
Revenue by Geography
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
| 9.68M | 3.93M | 6.23M | 26.68M | 13.89M | | | | | |
United States of America Growth | 146.73% | -36.95% | -76.66% | 92.07% | -55.76% | | | | | |
| - | - | - | 233.00K | 378.00K | | | | | |
| - | - | - | -38.36% | -36.47% | | | | | |
| 9.68M | 3.93M | 6.23M | 26.91M | 14.27M | | | | | |
| 146.73% | -36.95% | -76.87% | 88.61% | -55.40% | | | | | |
Source: S&P Global Market Intelligence.
